Insulet PODD
NASDAQ PODD
$134.58 -3.34 (-2.42%)
As of: Sep 10, 2026 · 2:54 PM EDT

Insulet (PODD) Non-Current Deferred Tax Liability (2010 - 2012)

Insulet's (PODD) quarterly Non-Current Deferred Tax Liability came in at $700000.0 in Q4 2012, down 22.22% on a YoY basis from $900000.0 in Q1 2012, and down 30.0% quarter-over-quarter from $1.0 million in Q3 2012.

Analysis

Insulet (PODD) Non-Current Deferred Tax Liability (2010 - 2012) Analysis & Trends

Insulet (PODD) has reported Non-Current Deferred Tax Liability for 3 consecutive years, with $700000.0 the latest figure, recorded in Q4 2012.

  • For the quarter ending Q4 2012, Non-Current Deferred Tax Liability fell 22.22% year-over-year to $700000.0; the trailing twelve-month figure through Dec 2012 stood at $700000.0 (down 22.22% YoY), and the FY2012 full-year result was $700000.0, down 22.22% from the prior year.
  • Non-Current Deferred Tax Liability declined to $700000.0 in Q4 2012 per PODD's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $5.5 million in Q2 2011 and bottomed at $700000.0 in Q4 2012.
  • Historically, Non-Current Deferred Tax Liability has averaged $1.6 million across 3 years, with a median of $1.0 million in 2012.
  • The widest YoY moves for Non-Current Deferred Tax Liability: up 22.22% in 2012, down 81.82% in 2012.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $1.4 million in 2010, then slumped by 35.76% to $900000.0 in 2011, then dropped by 22.22% to $700000.0 in 2012.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $700000.0, $1.0 million, and $1.0 million for Q4 2012, Q3 2012, and Q2 2012 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn
10 Insulet 9.35 Bn 8.82 Bn 562.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 700,000.00
Sep 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Mar 31, 2012 900,000.00
Dec 31, 2011 900,000.00
Jun 30, 2011 5.50 Mn
Dec 31, 2010 1.40 Mn